151 related articles for article (PubMed ID: 32042730)
21. Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice.
Denis M; Marcinkiewicz J; Zaid A; Gauthier D; Poirier S; Lazure C; Seidah NG; Prat A
Circulation; 2012 Feb; 125(7):894-901. PubMed ID: 22261195
[TBL] [Abstract][Full Text] [Related]
22. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
[TBL] [Abstract][Full Text] [Related]
23. Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis.
Liu Y; Fang X; Zhang X; Huang J; He J; Peng L; Ye C; Wang Y; Xue F; Ai D; Li D; Zhu Y
Br J Pharmacol; 2018 Apr; 175(8):1190-1204. PubMed ID: 28771708
[TBL] [Abstract][Full Text] [Related]
24. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional profiling analysis of HMP-treated rats with experimentally induced myocardial infarction.
Fan X; Shi M; Wang Y; Liang Q; Luo G
J Ethnopharmacol; 2011 Sep; 137(1):199-204. PubMed ID: 21605651
[TBL] [Abstract][Full Text] [Related]
26. Hawthorn Extract Alleviates Atherosclerosis through Regulating Inflammation and Apoptosis Related Factors: An Experimental Study.
Wang SZ; Wu M; Chen KJ; Liu Y; Sun J; Sun Z; Ma H; Liu LT
Chin J Integr Med; 2019 Feb; 25(2):108-115. PubMed ID: 30519874
[TBL] [Abstract][Full Text] [Related]
27. The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.
Miranda MX; van Tits LJ; Lohmann C; Arsiwala T; Winnik S; Tailleux A; Stein S; Gomes AP; Suri V; Ellis JL; Lutz TA; Hottiger MO; Sinclair DA; Auwerx J; Schoonjans K; Staels B; Lüscher TF; Matter CM
Eur Heart J; 2015 Jan; 36(1):51-9. PubMed ID: 24603306
[TBL] [Abstract][Full Text] [Related]
28. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
29. [Intervention of Huayu Qutan Recipe on liver SREBP-2 signal pathway of hyperlipidemia rats of pi deficiency syndrome].
Leng X; Jia LQ; Yang GL; Wang JY; Zhu ML; Wang Y; Xu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):320-6. PubMed ID: 25951638
[TBL] [Abstract][Full Text] [Related]
30. [Electroacupuncture improves glucose and lipid metabolism by regulating APN/AMPK/PPARα signaling of skeletal muscle in Zucker diabetic obese rats].
Duan HR; Li R; Song SS; Hu SQ; Zhuang ST; Li QY
Zhen Ci Yan Jiu; 2021 Nov; 46(11):907-13. PubMed ID: 34865326
[TBL] [Abstract][Full Text] [Related]
31. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
32. Luteolin decreases atherosclerosis in LDL receptor-deficient mice via a mechanism including decreasing AMPK-SIRT1 signaling in macrophages.
Li J; Dong JZ; Ren YL; Zhu JJ; Cao JN; Zhang J; Pan LL
Exp Ther Med; 2018 Sep; 16(3):2593-2599. PubMed ID: 30186491
[TBL] [Abstract][Full Text] [Related]
33. Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease.
Chang H; Wang Q; Shi T; Huo K; Li C; Zhang Q; Wang G; Wang Y; Tang B; Wang W; Wang Y
BMC Complement Altern Med; 2016 Mar; 16():103. PubMed ID: 27000070
[TBL] [Abstract][Full Text] [Related]
34. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S
J Lipid Res; 2014 Nov; 55(11):2370-9. PubMed ID: 25258384
[TBL] [Abstract][Full Text] [Related]
35. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited.
Basso F; Freeman LA; Ko C; Joyce C; Amar MJ; Shamburek RD; Tansey T; Thomas F; Wu J; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
J Lipid Res; 2007 Jan; 48(1):114-26. PubMed ID: 17060690
[TBL] [Abstract][Full Text] [Related]
36. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis.
Yu XH; Qian K; Jiang N; Zheng XL; Cayabyab FS; Tang CK
Clin Chim Acta; 2014 Jan; 428():82-8. PubMed ID: 24252657
[TBL] [Abstract][Full Text] [Related]
37. [Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice].
Zhang BC; Li XK; Che WL; Li WM; Hou L; Wei YD; Xu YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):143-9. PubMed ID: 23710746
[TBL] [Abstract][Full Text] [Related]
38. Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis.
Wang JK; Li Y; Zhao XL; Liu YB; Tan J; Xing YY; Adi D; Wang YT; Fu ZY; Ma YT; Liu SM; Liu Y; Wang Y; Shi XJ; Lu XY; Song BL; Luo J
Circulation; 2022 Mar; 145(9):675-687. PubMed ID: 35189703
[TBL] [Abstract][Full Text] [Related]
39. Standardized fraction of Xylocarpus moluccensis fruits improve vascular relaxation and plaque stability in dyslipidemic models of atherosclerosis.
Kanshana JS; Rebello SC; Pathak P; Kanuri BN; Aggarwal H; Srivastava V; Khanna V; Singh V; Jagavelu K; Barthwal MK; Dikshit M
J Ethnopharmacol; 2018 Mar; 213():81-91. PubMed ID: 29129602
[TBL] [Abstract][Full Text] [Related]
40. Carbenoxolone ameliorates hepatic lipid metabolism and inflammation in obese mice induced by high fat diet via regulating the JAK2/STAT3 signaling pathway.
Chen Y; Lu W; Jin Z; Yu J; Shi B
Int Immunopharmacol; 2019 Sep; 74():105498. PubMed ID: 31261036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
